Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
347 results about "Bifidobacterium animalis" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Bifidobacterium animalis is a gram-positive, anaerobic, rod-shaped bacterium of the Bifidobacterium genus which can be found in the large intestines of most mammals, including humans. Bifidobacterium animalis and Bifidobacterium lactis were previously described as two distinct species. Presently, both are considered B. animalis with the subspecies Bifidobacterium animalis subsp. animalis and Bifidobacterium animalis subsp. lactis.
Cholesterol absorption inhibitor
InactiveUS7993903B2Improve survivabilityInhibits Cholesterol AbsorptionBiocideBacteriaMicroorganismBlood cholesterol
Owner:YAKULT HONSHA KK
Bifidobacterium longum and applications thereof
ActiveCN107893044AImprove toleranceGood growth and acid productionBacteriaDigestive systemPhenolphthaleinFeces
The invention discloses bifidobacterium longum and applications thereof, and belongs to the technical field of microorganisms. The bifidobacterium longum is deposited in the China General Microbiological Culture Collection Center in Institute of Microbiology, Chinese Academy of Sciences at number 3, No.1 yard, Beichenxi road, Chaoyang district, Beijing on December 7, 2017, and the accession numberis CGMCC NO.15032. The bifidobacterium longum has good growth, acid production, and acid resistant properties, and high adhesive capacity, can significantly increase the water content of faeces and the pushing rate of small intestine of mice with constipation, shortens the first black stool evacuation time, relieves inflammation of colonic mucosas, and regulates contents of gastrointestinal peptides related to constipation in serum. A constipation relieving effect of the bifidobacterium longum is equivalent to that of bifidobacterium animalis BB12, but an effect of the bifidobacterium longumon the pushing rate of small intestine is superior to those of bifidobacterium animalis BB12 and phenolphthalein. Accordingly, the bifidobacterium longum strain CCFM760 can be widely applied in various foods or medicine matrixes.
Owner:上海华朴生命健康科技有限公司
Method for preparing traditional Chinese medicine fruit and vegetable enzyme beverage
The invention provides a method for preparing a traditional Chinese medicine fruit and vegetable enzyme beverage, and relates to the food field. The method comprises the steps: mixing a fruit and vegetable mixture with rock candy according to the mass ratio of 3:(0.5-1.5), placing the mixture in a fermentation tank, and in a sealed state and under a condition of the temperature of 2-30 DEG C, fermenting for 160-200 days, to obtain a fruit and vegetable fermented liquid; mixing the fruit and vegetable fermented liquid with a traditional Chinese medicine decoction liquid, inoculating with one or two or more of lactobacillus delbrueckii subsp.bulgaricus, lactobacillus plantarum subsp.plantarum, yeast and bifidobacterium animalis, and in a sealed state and at the temperature of 35-40 DEG C, fermenting for 3-8 days, to obtain the traditional Chinese medicine fruit and vegetable enzyme beverage. The medicine and food homology and mutual harmony and complementation effects are achieved; the obtained traditional Chinese medicine fruit and vegetable enzyme beverage has the advantages of high total phenol content, high DPPH(.) scavenging rate and high SOD enzyme activity, shows strong antioxidant capacity, can improve the human body gastrointestinal health-care functions, and can be used as a daily drinking health drink.
Owner:NANJING UNIV OF TECH
Novel strain of bifidobacterium animalis subsp. lactis cect 8145 and use thereof for the treatment and/or prevention of excess weight and obesity and associated diseases
ActiveUS20160143963A1Low in fatReduce the impactBiocideMilk preparationMetabolitePharmaceutical formulation
The invention is applicable within the food and pharmaceutical industry. More specifically, it relates to a novel strain of the species Bifidobacterium animalis subsp. lactis CECT 8145, the cell components, metabolites and secreted molecules thereof, which, incorporated into food and / or pharmaceutical formulations, can be used in the treatment and / or prevention of excess weight and obesity and related diseases such as metabolic syndrome, hypertension, glycemia, inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolemia, hormonal alterations, infertility, etc.
Owner:BIOPOLIS
High-density culture method of bifidobacterium lactis and preparation method of freeze-dried powder of bifidobacterium lactis
ActiveCN103898018AStrong toleranceReduce mortalityBacteriaMicroorganism based processesFreeze-dryingCulture mediums
The invention relates to a high-density culture method of bifidobacterium lactis V9 and a preparation method of a freeze-dried powder of the bifidobacterium lactis V9, and belongs to the field of probiotics fermentation. The bifidobacterium lactis V9 (Bifidobacterium animalis subsp.lactis V9) is acid-resistant and cholate-resistant probiotics which are separated from the intestinal tract of a healthy Mongolian child, and the collection number of the bifidobacterium lactis V9 is CGMCC No.5470. High-density fermentation of the bacteria of the bifidobacterium lactis V9 is realized under the control of an optimized culture medium and optimized fermentation conditions; the viable count in a fermentation liquor can be more than 2.0*10<10>cfu / ml, and the viable count in the freeze-dried powder of the bifidobacterium lactis prepared by using the fermentation liquor can be more than 6.0*10<11>cfu / g, and therefore, the freeze-dried powder of the bifidobacterium lactis can be applied to a probiotic leavening agent or a probiotic preparation.
Owner:BEIJING SCITOP BIO TECH CO LTD
Compound probiotic agent for improving immunity of dogs and reducing incidence of diarrhea as well as preparation method and application thereof
ActiveCN107058158AImprove immunityControl white blood cell countBacteriaDigestive systemInterleukin 6Feces
The invention discloses a compound probiotic agent for improving immunity of dogs and reducing incidence of diarrhea as well as a preparation method and application thereof, and belongs to the field of the compound probiotic agent. The compound probiotic agent is prepared by mixing and compounding a lactobacillus plantarum KT-Lp9 microbial agent, a lactobacillus casei zhang microbial agent, a lactobacillus plantarum P-8 microbial agent, a bifidobacterium animalis subsp. lactis V9 microbial agent and a dilution carrier, wherein the quantity of viable bacteria of the four kinds of microbial agents is more than or equal to 2*10<11>CFU / g. The compound probiotic agent with different contents of viable bacteria only can be applied to 96 dogs at different ages for 60 days, so that the immunity of the test dogs can be improved, and the incidence of diarrhea and the sickness degree are reduced. Main representations are that the feed intake and growth rate of the dogs are increased, leukocyte counts, lymphocytes counts and neutrophil counts in blood are controlled, and the contents of four immunologic factors including immune globulin G, interleukin 6, interferon alpha and tumor necrosis factor alpha in the blood can be increased; and meanwhile, the content of secretory immunoglobulin A (SigA) in excrement is increased.
Owner:INNER MONGOLIA SCI PLUS BIOTECH
Cholesterol absorption inhibitor
ActiveUS20090170185A1Improve survivabilityInhibits Cholesterol AbsorptionBiocideBacteriaCholesterol absorption inhibitorHigh survival rate
To provide a bacterium belonging to the genus Bifidobacterium which is excellent in a survival ability in the gastrointestinal tract, has an effect of inhibiting the cholesterol absorption in the intestinal tract, and is excellent in lipid metabolism ameliorating effects including decreasing the blood cholesterol level and the like, and shows a high survival rate after storage, and a cholesterol absorption inhibitor using the same. The invention provides a cholesterol absorption inhibitor containing, as an active ingredient, at least one microorganism selected from Bifidobacterium animalis subsp. animalis YIT 10394, Bifidobacterium animalis subsp. lactis JCM 1253, Bifidobacterium animalis subsp. lactis JCM 7117, and Bifidobacterium pseudolongum subsp. globosum.
Owner:YAKULT HONSHA KK
Compound probiotics capable of relieving ulcerative colitis, preparation method and application thereof
ActiveCN113430133AGood synergyLower disease activity indexBacteriaAntipyreticBiotechnologyUlcerative colitis
The invention discloses compound probiotics capable of relieving ulcerative colitis, a preparation method and application thereof, and relates to the technical field of microorganisms. The compound probiotics are characterized by comprising Bifidobacterium longum BL21, Bifidobacterium animalis subsp.lactis BLa80 and Lactobacillus casei LC89. The preparation method comprises the following steps of: respectively preparing freeze-dried powder of the Bifidobacterium longum BL21, the Bifidobacterium animalis subsp.lactis BLa80 and the Lactobacillus casei LC89; and uniformly mixing the three freeze-dried powder in proportion to prepare the compound probiotics. The compound probiotics provided by the invention can prevent and / or treat ulcerative colitis, and have a great application prospect in preparation of products (such as solid beverages) for preventing and / or treating ulcerative colitis.
Owner:JIANGSU WECARE BIOTECHNOLOGY CO LTD
Lactobacillus casei, bifidobacterium animalis, lactobacrillus plantarum and bacillus subtilis for solid fermentation of probiotics in field of feed additives
ActiveCN103421711AReduce manufacturing costLess investmentBacteriaAnimal feeding stuffLactobacillus plantarumBifidobacterium animalis
The invention provides lactobacillus casei, bifidobacterium animalis, lactobacrillus plantarum and bacillus subtilis for solid fermentation of probiotics in the field of feed additives. The lactobacillus casei, bifidobacterium animalis, lactobacrillus plantarum and bacillus subtilis are characterized in that the bacillus subtilis HM-66, the lactobacillus casei F-08, the lactobacillus plantarum HM-20 and the bifidobacterium animalis V9 are all probiotics, and are preserved in the general microbiological culture collection center of the Chinese microbiological culture collection management committee with the preservation numbers of CGMCC No.6733, CGMCC No.6735, CGMCC No.6744 and CGMCC No.5470 respectively; the preservation dates of the bacillus subtilis HM-66, the lactobacillus casei F-08 and the lactobacillus plantarum HM-20 are October 29th, 2012, and the preservation date of the bifidobacterium animalis V9 is November 18th, 2011. The invention further discloses an application method of the lactobacillus casei, bifidobacterium animalis, lactobacrillus plantarum and bacillus subtilis.
Owner:INNER MONGOLIA SCI PLUS BIOTECH
Probiotic composition for relieving anxiety or depression and application thereof
ActiveCN111728111AImprove growth efficiencyIncrease the number ofMilk preparationNervous disorderBiotechnologyDisease
The invention discloses a probiotic composition for relieving anxiety or depression and an application thereof. The probiotic composition comprises prebiotics, a K-KLJ probiotic combination and functional substances. The K-KLJ probiotic composition contains at least one of lactobacillus plantarum, lactobacillus reuteri, lactobacillus casei, and lactobacillus helveticus, or also contains at least one of lactobacillus rhamnosus, lactobacillus acidophilus, bifidobacterium animalis and bifidobacterium longum. The probiotic composition of the present invention can significantly increase quantity ofbeneficial intestinal flora, improve intestinal discomfort, and reduce chronic inflammation, thereby reducing unhealthy emotion, and preventing emotional diseases such as depression and anxiety. Moreover, according to the invention, the combination of probiotic strains, the prebiotics, the probiotic strains and the functional substances have effect of significant synergistic enhancement.
Owner:WUHAN KANGFUDE BIOTECH CO LTD
Fragrant pig derived cholesterol-assimilating and oxygen-resistant bifidobacterium BZll
Provided is fragrant pig derived cholesterol-assimilating and oxygen-resistant bifidobacterium BZll. The fragrant pig derived cholesterol-assimilating and oxygen-resistant bifidobacterium BZll is Bifidobacterium animalis subsp.Lactis, the pure culture of the fragrant pig derived cholesterol-assimilating and oxygen-resistant bifidobacterium BZll is preserved at the China General Micro-biological Culture Collection Center (CGMCC), China Microbial Culture Preservation Management Committee, the address is Institute of Microbiology, Institution No.3 China Academy of Science, Western Beichen Road No.1 in Chaoyang District of Beijing in China, the postal code is 100101, the preservation number is CGMCC NO.10224, and the Bifidobacterium animalis subsp.Lactis BZll is called for short. The Bifidobacterium animalis subsp.Lactis BZll is high in cholesterol-assimilating capacity, acid resistance and cholate resistance, good in oxygen resisting performance, has probiotic property and can serve as probiotics to be added into a fermentative milk product to produce a functional food, bifidobacterium culture resources are enriched, and development of bifidobacterium health-care products is facilitated.
Owner:奈安制药(中国)有限公司
Bifidobacterium animalis subsp. Lactis i797, purification method and application thereof
ActiveCN111484957AGood for intestinal regulationEnsure balanceMilk preparationBacteriaBiotechnologyLactic acid bacterium
Owner:JUNLEBAO DAIRY GRP CO LTD
Composite probiotic lactobacillus powder as well as preparation method and application thereof
ActiveCN108004189AImprove acid resistanceGood artificial gastric juicePowder deliveryOrganic active ingredientsGut floraMaterials science
The invention provides composite probiotic lactobacillus powder as well as a preparation method and application thereof. The composite probiotic lactobacillus powder is prepared by compounding lactobacillus casei Zhang powder, bifidobacterium animalis V9 powder, lactobacillus plantarum P-8 powder, lactobacillus plantarum C2 powder, prebiotics and fruit and vegetable powder. The composite probioticlactobacillus powder has the remarkable protective effect on irritable bowel syndrome, oral infection and nasal infection, has the remarkable prevention effect on occurrence of upper respiratory infection, can improve gastrointestinal symptoms and adjust intestinal flora, and can improve the immunity of the organism.
Owner:BEIJING SCITOP BIO TECH CO LTD
Probiotic composition for relieving anxiety and depression, regulating bad mood, relieving pressure and helping sleep and preparation method and applications thereof
PendingCN110140968AGood synergyPromote growth and reproductionFood ingredient functionsOligosaccharide food ingredientsLactobacillus rhamnosusAnxiety
The invention provides a probiotic composition and a preparation method and applications thereof, and belongs to the technical field of health-care foods. The probiotic composition comprises probiotics and prebiotics. The probiotics comprise lactobacillus acidophilus NCFM, lactobacillus rhamnosus HN001, lactic acid bacteria composite powder GI, lactic acid bacteria composite powder OH, bifidobacterium animalis B94, bifidobacterium bifidum R0071, lactobacillus casei R0215, live bacillus coagulans GBI30,6086 and lactobacillus rhamnosus GG. The prebiotics include fructo-oligosaccharides, resistant dextrins and lactitol. The mass ratio of the probiotics to the prebiotics is (300-350):(1300-1400). The total viable bacteria concentration of the probiotics in the probiotics composition is more than or equal to 9.0x10<9> CFU / g. The probiotic composition provided by the invention can obviously improve sleep quality, and significantly relieve anxiety and depression.
Owner:GUANGZHOU KANGZE MEDICAL TECH CO LTD
Micro-ecological composition for improving constipation by targeting intestinal flora and preparation of micro-ecological composition
InactiveCN111671791ARestore gut microbiomeEasy to adjustOrganic active ingredientsDigestive systemBiotechnologyLactobacillus acidophilus
The invention discloses a micro-ecological composition for improving constipation by targeting intestinal flora and a preparation of the micro-ecological composition. The micro-ecological compositioncomprises probiotics, prebiotics and medicinal and edible traditional Chinese medicines, wherein the probiotics are selected from at least one of bifidobacterium animalis, bifidobacterium adolescentis, bifidobacterium longum, bifidobacterium breve, lactobacillus rhamnosus, lactobacillus acidophilus, lactobacillus helveticus, lactobacillus plantarum, lactobacillus reuteri, lactobacillus paracasei and bacillus coagulans; the prebiotics are selected from at least one of stachyose, fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, inulin, resistant dextrin and xylooligosaccharide; and the medicinal and edible traditional Chinese medicines are selected from at least one of semen sesami nigri, semen cassiae, fructus cannabis, honey, semen lablab album, semen coicis, poria cocos and lotus leaves. The micro-ecological composition can effectively regulate intestinal tract micro-ecology in a targeted mode, and finally the purpose of improving constipation is achieved.
Owner:SUN YAT SEN UNIV
Granulation-resisting lactic acid bacterium preparation and preparation method thereof
ActiveCN107815429AImprove toleranceAvoid lostBacteriaMicroorganism based processesLactobacillus buchneriLactobacillus acidophilus
The invention provides a granulation-resisting lactic acid bacterium preparation and a preparation method thereof. The granulation-resisting lactic acid bacterium preparation comprises lactic acid bacterium; the lactic acid bacterium is one or a combination of more of enterococcus faecalis, enterococcus faecium, lactobacillus plantarum, lactobacillus acidophilus, lactobacillus lactis, lactobacillus buchneri, lactobacillus casei and bifidobacterium animalis; a viable count of the lactic acid bacterium reaches 1.0*10<10> to 1.0*10<11>CFU / g. According to the preparation method of the lactic acidbacterium preparation, provided by the invention, the tolerance of thalli is improved and the loss of bacterium activity in a processing process is avoided.
Owner:BEIJING HESWOF BIOTECH CO LTD
Xylooligosaccharide with low DP (degree of polymerization) as well as preparation method and application of xylooligosaccharide
PendingCN106636256AHigh dissolution ratePromote degradationBacteriaMicroorganism based processesFiberEnzymatic hydrolysis
The invention discloses a preparation method of xylooligosaccharide with low DP (degree of polymerization). The preparation method is characterized by comprising steps as follows: (1) wood fiber biomass is taken as a raw material and subjected to diluted acid / diluted base / hot water pretreatment, a liquid is filtered, a solid phase is treated in a high-temperature degrading or steam explosion pretreatment manner, and the wood fiber biomass is cooled for later use; (2) xylanase is added to a pretreatment solution in step (1) for an enzymatic hydrolysis reaction; (3) an enzymatic hydrolysis solution is treated through enzyme deactivation, purification, concentration and drying, and xylooligosaccharide with low DP is prepared. The DP of finally obtained xylooligosaccharide is low by reasonably optimizing each process step, and xylobiose, xylotriose and xylotetraose are taken as main components, so that the functionality of xylooligosaccharide as a bifidus factor is enhanced. Tests verify that prepared xylooligosaccharide has a good proliferative effect on bifidobacterium animalis and lactobacillus casei. The process is simplified, the product quality is improved, and xylooligosaccharide has good application prospect.
Owner:SHANDONG LONGLIVE BIO TECH CO LTD
Compound probiotic fermentation product having effect of protecting skins, and preparation and applications thereof
ActiveCN112980892AMaintain balanceIncrease elasticityCosmetic preparationsBacteriaBiotechnologyMetabolite
The invention belongs to the field of microbial fermentation, and especially relates to a fermentation metabolite having an effect of protecting skins, and a preparation method and applications thereof. The product is prepared by taking lactobacillus plantarum, lactobacillus casei, lactobacillus lactentis, bifidobacterium animalis and lactobacillus rhamnosus as fermentation strains and taking sucrose, seaweed meal, soybean meal and milk powder as fermentation raw materials through mixing and fermentation. The product contains specific fermentation metabolites, such as malonylgenistin, genistein, hyaluronic acid, irone, Preaustinoid A and daidzein, which are helpful for the enhancement of a skin protection effect; and tartaric acid, malic acid, succinic acid, salicylic acid, vanillic acid, phenylpropionic acid and other organic acid generated by fermentation can control pathogenic bacteria and spoilage microbial flora, so that skin flora balance can be maintained, and a natural antiseptic effect can be achieved. Efficacy tests show that the product has the efficacy of removing wrinkles, increasing skin elasticity, resisting inflammation and repairing skin barriers, and is significant in effect.
Owner:青岛元达生物科技有限公司
Five-probiotic nutritive powder and preparation method thereof
InactiveCN107212415AHigh adhesion rateEnhance colonization abilityLactobacillusBifidobacteriumLactobacillus rhamnosusOligosaccharide
Owner:江西长通实业有限公司
Bifidobacterium animalis NX-6 and application thereof in preparation of lipid-lowering and weight-losing medicines
The invention discloses bifidobacterium animalis NX-6 and application thereof in preparation of lipid-lowering and weight-losing medicines, and belongs to the technical field of microorganisms. The preservation number of the bifidobacterium animalis NX-6 disclosed by the invention is CGMCC (China General Microbiological Culture Collection Center) No. 20114. The uninactivated and inactivated fermentation supernate, bacterial suspension and cell disrupted supernate of novel bifidobacterium animalis NX-6 show good effects of slowing down weight and body length increase, improving body mass index(BMI) and reducing fat area percentage on zebrafish, and have a potential weight losing effect; triglyceride (TG) and total cholesterol (TC) in a zebrafish hyperlipidemia model body can be obviously reduced, and a good hypolipidemic effect is shown. The novel bifidobacterium animalis NX-6 disclosed by the invention has a huge potential application prospect in the aspect of preparing medicines fortreating and / or preventing obesity and hyperlipidemia.
Owner:广东南芯医疗科技有限公司 +1
Bifidobacterium animalis and application thereof in preparing bifidobacterium fermented beverage
ActiveCN102010845AAntioxidantWith adverse environmentBacteriaFood scienceFood flavorBifidobacterium longum
The invention discloses a bifidobacterium animalis and application thereof in preparing a bifidobacterium fermented beverage. The bifidobacterium animalis is bifidobacterium animalis 01, and has the preservation number of CGMCC 1353. The bifidobacterium animalis 01 with the preservation number of CGMCC 1353 can be used for preparing the bifidobacterium fermented beverage. The prepared yacon bifidobacterium fermented beverage has mild color (as shown in figure 1), good mouth feel, good flavor and longer shelf life, and is a health beverage with a good health-care effect.
Owner:哈尔滨美华生物技术股份有限公司
Compound probiotics lactobacillus powder for treating irritable bowel syndrome (IBS) and application thereof
ActiveCN110169983AEffective treatmentSymptoms improvedPowder deliveryOrganic active ingredientsGut floraNutrients substances
The application provides compound probiotics powder for treating irritable bowel syndrome (IBS). The compound probiotics powder is prepared from lactobacillus casei Zhang, bifidobacterium animalis subsp. lactis V9 and lactobacillus plantarum P-8; the compound probiotics powder is obtained through optimizing, compounding and combining nutrient substances with different properties; the compound probiotics powder can regulate intestinal flora, effectively treats the IBS, can obviously improve symptoms, and reduces inflammatory responses, thereby solving the problems that existing compound probiotics lactobacillus powder is single in flora composition, low in viable count, and poor in probiotics safety, and is lacking in probiotics preparations which effectively treat the IBS; the compound probiotics powder has wide market prospects.
Owner:BEIJING SCITOP BIO TECH CO LTD
Bifidobacterium animalis with bowel relaxing function as well as application and preparation of bifidobacterium animalis
ActiveCN111826299AGood laxative functionImprove oxygen resistanceOrganic active ingredientsBacteriaBiotechnologyIntestino-intestinal
The invention discloses Bifidobacterium animalis with a bowel relaxing function and application and a preparation of the Bifidobacterium animalis. According to the Bifidobacterium animalis, Bifidobacterium lactis BB-11 is separated from an intestinal content of healthy and long-lived elderly people in Bama, Guangxi, the strain is carried on a spacecraft, finally, a Bifidobacterium animalis MN-Gupwith significantly improved oxygen resistance or significantly enhanced oxygen resisting capacity is screened by space mutagenesis, and evaluation of constipation model mice proves that the strain hasthe good bowel relaxing function and has broad application prospects in bowel relaxing drugs, health foods and foods.
Owner:INNER MONGOLIA MENGNIU DAIRY IND (GRP) CO LTD
Repairing and soothing skin care product containing metagen component and preparation method thereof
ActiveCN112999143AIncrease elasticityEliminate wrinklesCosmetic preparationsToilet preparationsBiotechnologyLactobacillus rhamnosus
The invention provides a repairing and soothing skin care product containing a postbiotic component and a preparation method thereof. The repairing and soothing skin care product comprises the following components in percentage by mass: 1-5% of the postbiotic component, 1-8% of grease, 3-5% of a skin conditioner, 9-15% of a humectant, 0.5-8% of a surfactant, 0.6-1.2% of a thickening agent and the balance being deionized water. The postbiotic component comprises an antibacterial substance and an active metabolite, has the effects of reconstructing skin cells, improving elastin and updating metabolism of a corium layer, and has an effect of promoting proliferation of cuticle cells, and the prepared skin care product can enhance skin elasticity and has obvious skin soothing and repairing effects. According to the invention, the postbiotic component is a mixed solution obtained by fermenting a variety of strains such as lactobacillus plantarum, lactobacillus casei, bifidobacterium lactis, bifidobacterium animalis and lactobacillus rhamnosus; compared with a postbiotic component obtained by single strain fermentation, the effect of eliminating wrinkles and enhancing skin elasticity is better, and the multi-dimensional skin problem can be solved.
Owner:青岛元达生物科技有限公司
Probiotics-containing breast milk-like formula milk powder for infants and preparation method of milk powder
InactiveCN110506793APromote brain developmentImprove memoryMilk preparationBrain developmentDocosahexaenoic acid
The invention discloses a probiotics-containing breast milk-like formula milk powder for infants. Raw milk is used as a base material; according to nutrient differences of breast milk and raw milk, whey protein is added to adjust the ratio of whey protein to casein in a product to be close to 6:4; soybean oil is added to adjust deficiency of linoleic acid in milk fat, wherein linoleic acid accounts for about 12.8 percent of the total fat of the breast milk but only 2.2 percent of the total fat of raw milk; arachidonic acid (AA), docosahexaenoic acid (DHA), sialic acid (SA) and 3'-sialyllactose(3'-SL) are added to promote brain development of infants and improve memory and intelligence; and bifidobacterium lactis HN019, bifidobacterium animal Bb-12 and lactobacillus paracasei N1115 are added to regulate intestinal healthy development of infants. The invention also provides a preparation method of the milk powder. The milk powder is close to the nutrition index in the Chinese breast milk and is suitable for growth and development of infants in China.
Owner:JUNLEBAO DAIRY GRP CO LTD
Composition for resisting helicobacter pylori and application of composition
InactiveCN109480231AAvoid infectionImprove taste and flavorAntibacterial agentsOrganic active ingredientsBacteroidesOral bacterial infection
The invention provides a composition for resisting helicobacter pylori and an application of the composition. Each 100g of the composition comprises the following active components according to the content: 5-20g of inactivated lactobacillus reuteri, 0.1-1g of inactivated lactobacillus paracasei, 1.5-25g of bifidobacterium animalis viable bacteria, 1.2-20g of lactobacillus rhamnosus, 5-10g of hippophae rhamnoides fruit powder, 0.1-1g of a broccoli seed aqueous extract, 20-30g of fructo-oligosaccharide and 10-70g of lacitiol. According to the composition, the inactivated lactobacillus reuteri,the inactivated lactobacillus paracasei, the hippophae rhamnoides fruit powder, the broccoli seed aqueous extract, the fructo-oligosaccharide and the lacitiol are prepared into a specific compositionformula together, and the formula not only can well prevent and treat bacterial infection of gastrointestinal tracts and bacterial infection of oral cavities, particularly concurrently has better mouth feel flavor, and is green and healthy due to no addition of seasonings of essence and the like.
Owner:GUANGZHOU PROFORCARE PHARMA INC
Soybean milk beverage prepared through using Lactobacillus casei Zhang and Bifidobacterium animalis subsp.lactis V9, and its preparation method
InactiveCN102813004AHigh survival contentPrevent constipationMilk substitutesFood scienceSucroseSaccharum
The invention discloses a soybean milk beverage prepared through using Lactobacillus casei Zhang and Bifidobacterium animalis subsp.lactis V9, and its preparation method. A technical scheme adopted in the invention is that the soybean milk beverage is characterized in that the beverage is composed of 300kg of soybean milk or soybean powder reduction milk, 10-15kg of glucose, 100-120kg of sucrose, 2-4kg of a stabilizing agent, 0.1-0.3kg of an acid solution, 0.1-0.3kg of an edible perfume, 0.015-0.03kg of a Lactobacillus casei Zhang fermentation agent, and 0.015-0.03kg of a Bifidobacterium animalis subsp.lactis V9 fermentation agent, wherein strains of the above fermentation agents are preserved in China General Microbiological Culture Collection Center, and the preservation numbers of the strains are CGMCC No.5469 and CGMCC No.5470 respectively. The invention discloses the preparation method of the beverage.
Owner:北京和美科盛生物技术有限公司
Probiotic composition and preparation method and application thereof
ActiveCN113151056ASurprised by the technical effectRelieve constipation somatosensory effectBacteriaDigestive systemBiotechnologyProbiotic bacterium
The invention provides a probiotic composition and a preparation method and application thereof. The probiotic composition comprises raw materials of lactobacillus reuteri, lactobacillus acidophilus and bifidobacterium animalis, wherein the weight ratio of the lactobacillus reuteri to the lactobacillus acidophilus to the bifidobacterium animalis is (1.5-2.5):(0.5-1.5):(0.5-1.5). The colony forming units of the lactobacillus reuteri, the lactobacillus acidophilus or the bifidobacterium animalis in unit weight are the same. The lactobacillus reuteri is preserved in China Center for Type Culture Collection with the preservation number of 209138, and the lactobacillus acidophilus and / or the bifidobacterium animalis preserved in China General Microbiological Culture Collection Center with the preservation number of CGMCC 15210 are / is bifidobacterium animalis BB-115. The probiotic composition can relieve the symptom of slow transit constipation under the condition of low dosage, and can remarkably and effectively regulate gastrointestinal regulatory peptide indexes related to constipation, such as P substance (SP), gastrin (Gas) and vasoactive peptide (VIP).
Owner:SIRIO PHARMA CO LTD
Probiotic composition for enhancing immunity and application of probiotic composition
PendingCN112056399AIncrease the number ofImprove transformation abilityMilk preparationYeast food ingredientsLactobacillus rhamnosusProbiotic bacterium
The present invention discloses a probiotic composition for enhancing immunity and an application of the probiotic composition. The probiotic composition comprises prebiotics, a K-MYL probiotic combination and functional substances, and the K-MYL probiotic combination comprises at least one of lactobacillus casei, lactobacillus bulgaricus, saccharomyces boulardii, lactobacillus reuteri and bifidobacterium animalis, or further comprises at least one of lactobacillus rhamnosus, lactobacillus acidophilus and bifidobacterium longum. The probiotic composition can significantly increase the number of intestinal effective microbial communities, improve intestinal immune functions, improve expressions of intestinal immune factors, resist virus infection and shorten recovery time after the virus infection. Moreover, probiotic strain combinations, the prebiotics, probiotic strains and the functional substances have remarkable synergistic enhancement effects.
Owner:WUHAN KANGFUDE BIOTECH CO LTD
Fermented jujube food used for tonifying Qi and blood and preparation method thereof
InactiveCN109645281AIncrease diversityGood colorBacteriaMicroorganism based processesNutritive valuesNutrition
The invention belongs to the field of microbial fermentation application, and relates to a functional food produced by fermenting jujube, soybean meal, angelica sinensis, radix astragali and the likeby using probiotics and a preparation method of the functional food. The fermented food is prepared in the steps that the probiotics including lactobacillus plantarum, bifidobacterium animalis, bifidobacterium adolescentis, bacillus coagulans and lactobacillus paracasei are utilized to liquid state or solid state fermentation of the jujube, the soybean meal, angelica sinensis powder, radix astragali powder and the like. The fermented beverage and food preserve nutritive values of natural plants and have the nutrition and health care functions of probiotics fermented products, the taste is unique, the function is obvious, the functional food has an important adjustment effect on deficiency of Qi and blood and menoxenia of women, and the functional food has the functions of promoting blood circulation to arrest pain.
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com